Prikaz osnovnih podataka o dokumentu
Characteristics of novel pharmaceutical preparations for hormone replacement therapy in menopause
Karakteristike savremenih farmaceutskih preparata za terapijsku supstituciju hormona u menopauzi
dc.creator | Primorac, Marija | |
dc.creator | Đorđević, Ljiljana | |
dc.creator | Vasiljević, Dragana | |
dc.date.accessioned | 2019-09-02T11:01:14Z | |
dc.date.available | 2019-09-02T11:01:14Z | |
dc.date.issued | 2005 | |
dc.identifier.issn | 0004-1963 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/601 | |
dc.description.abstract | Hormone replacement therapy (HRT) is a well-established treatment for the relief of menopausal symptoms. Estrogens constitute the basis of HRT, and there are a number of different estrogens used. Estrogen can be administered orally in tablet form; locally in the vagina such as intravaginal creams and ring systems; percutaneously using a gel and emulsion; or transdermally using transdermal patches, and intranasal via intranasal spray. Selection of HRT should be based upon symptom type and severity, lowest effective dose, shortest duration of treatment, and patient preference. In this paper, characteristics of novel estrogen delivery systems were presented. | en |
dc.publisher | Savez farmaceutskih udruženja Srbije, Beograd | |
dc.rights | openAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-sa/4.0/ | |
dc.source | Arhiv za farmaciju | |
dc.subject | HRT | en |
dc.subject | estrogens | en |
dc.subject | drug delivery systems | en |
dc.subject | transdermal patches | en |
dc.subject | vaginal ring | en |
dc.subject | intrauterine device | en |
dc.subject | intranasal spray | en |
dc.subject | subcutaneous implant | en |
dc.subject | estrogeni | sr |
dc.subject | terapijski sistemi | sr |
dc.subject | transdermalni flasteri | sr |
dc.subject | vaginalni prsten | sr |
dc.subject | intrauterini uložak | sr |
dc.subject | nazalni sprej | sr |
dc.subject | implant | sr |
dc.title | Characteristics of novel pharmaceutical preparations for hormone replacement therapy in menopause | en |
dc.title | Karakteristike savremenih farmaceutskih preparata za terapijsku supstituciju hormona u menopauzi | sr |
dc.type | article | |
dc.rights.license | BY-SA | |
dcterms.abstract | Васиљевић, Драгана; Приморац, Марија; Ђорђевић, Љиљана; Карактеристике савремених фармацеутских препарата за терапијску супституцију хормона у менопаузи; Карактеристике савремених фармацеутских препарата за терапијску супституцију хормона у менопаузи; | |
dc.citation.volume | 55 | |
dc.citation.issue | 2 | |
dc.citation.spage | 131 | |
dc.citation.epage | 147 | |
dc.citation.other | 55(2): 131-147 | |
dc.identifier.fulltext | https://farfar.pharmacy.bg.ac.rs//bitstream/id/2103/599.pdf | |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_farfar_601 | |
dc.type.version | publishedVersion |